Pictured: Dr Hui Emma Zhang, Professor Mark Gorrell and Dr Avik Majumdar
Collaborative research between the Centenary Institute and Royal Prince Alfred Hospital has been recognised with a prestigious award.
Dr Avik Majumdar, a staff specialist transplant hepatologist at RPA Hospital, is among six recipients of the 2019 Gilead Australia Fellowship Program, which awarded a total of $250,000 for these six research projects.
Dr Majumdar has been collaborating with several Centenary researchers on the project, including Head of the Liver Enzymes in Metabolism and Inflammation Program Professor Mark Gorrell, Head of the Liver injury and Cancer Program Professor Geoff McCaughan, and Dr Hui Emma Zhang.
The group is working to validate an alternative test for people with non-alcoholic fatty liver disease (NAFLD), to understand whether a patient is at risk of developing more severe disease, and requires further treatment.
Congratulations Dr Majumdar and your collaborators at Centenary on this significant achievement!
Read about how Dr Hui Emma Zhang led a recent study, which discovered dozens of new likely targets for particular enzyme (FAP) that is within most tumours.
Research from the Centenary Institute has found that the human enzyme DPP4 does not enable COVID-19 infection in our bodies.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.